Evidence map›Paper›PMID 40800226›Full record

ArticleFrontiers in veterinary science2025

Treats containing cannabidiol, L-tryptophan and

Hannah E Flint, Jennifer E Weller, Alysia B G Hunt, Tammie King

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hannah E FlintWaltham Petcare Science Institute, Melton Mowbray, United Kingdom.
Jennifer E WellerWaltham Petcare Science Institute, Melton Mowbray, United Kingdom.
Alysia B G HuntWaltham Petcare Science Institute, Melton Mowbray, United Kingdom.
Tammie KingWaltham Petcare Science Institute, Melton Mowbray, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Demand for stress-reducing products aimed at pets has risen in recent years, demonstrated by an ever-growing market of nutritional and odor-based products. Previous research has demonstrated an effect of Cannabidiol (CBD), L-tryptophan and Methods: A blinded cross-over study was performed in which 54 dogs received a single dose of each treatment two hours prior to exposure to a previously developed stress paradigm (10 min. car travel). A range of behavioural and physiological measures were collected pre/post (plasma CBD levels, serum cortisol) or during (heart rate, heart rate variability, surface temperature, activity, posture, stress-related behaviours, qualitative ratings) the stress paradigm. Results: All treatments resulted in elevated post-test CBD levels in the plasma in comparison to placebo ( Discussion: CBD combined with the blend had a mild stress-reducing effect in dogs. Further exploration of the efficacy of CBD in reducing stress and anxiety, including interactions with different active ingredients and individual differences in absorption and metabolism are warranted.

Indexed as

animal welfarecannabidiolCBDdogstresstransportationtryptophanα-casozepine

Identifiers

PMID40800226
PMCPMC12339541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.